Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bypass Surgery Shows Long-Term Survival Advantage Over Stenting

This article was originally published in The Gray Sheet

Executive Summary

Drug-eluting stent manufacturers with an eye toward multi-vessel and diabetic-specific indications face a new hurdle in the recent release of observational data pointing to lower mortality among patients receiving bypass surgery compared with stenting
Advertisement

Related Content

Boston Scientific To Study Complex DES Use; Taxus Complaints Surface
Boston Scientific To Study Complex DES Use; Taxus Complaints Surface
Advertisement
UsernamePublicRestriction

Register

MT020174

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel